Immunotherapy for pediatric solid tumors

Lisa M. Kopp, Emmanuel Katsanis

Research output: Chapter in Book/Report/Conference proceedingChapter


Although the cure rates for pediatric and adolescent cancer continue to increase, many solid tumor malignancies continue to have overall worse outcomes when compared to acute lymphoblastic leukemia and lymphomas. This is especially true for metastatic or recurrent solid tumors. Immunotherapy may impact how we treat these tumors. Although the number of immunotherapy clinical trials in pediatric patients has been small compared to adults, the results are promising even in patients with advanced disease and should be explored further. In this chapter we will review the different immunotherapeutic approaches that have and are being evaluated in the pediatric oncology setting.

Original languageEnglish (US)
Title of host publicationCancer Immunology
Subtitle of host publicationCancer Immunotherapy for Organ-Specific Tumors
PublisherSpringer Berlin Heidelberg
Number of pages21
ISBN (Electronic)9783662464106
ISBN (Print)9783662464090
StatePublished - Jan 1 2015


  • Children
  • Immunotherapy
  • Solid tumor

ASJC Scopus subject areas

  • General Medicine
  • General Immunology and Microbiology


Dive into the research topics of 'Immunotherapy for pediatric solid tumors'. Together they form a unique fingerprint.

Cite this